 | | Whitepaper The IVDR Journey: A roadmap to meet 2022 deadlines |  | |
| | The COVID-19 pandemic has had an immediate impact on the medical device industry, including in vitro diagnostics (IVD). Despite this, it is unlikely that the May 2022 deadline for implementation of the In Vitro Diagnostics Regulations (IVDR) will be delayed. The IVD industry has made slow progress toward meeting the IVDR deadline which may have a profound impact on market access to products and, ultimately, patient outcomes. | | |
| | Read our whitepaper to learn more about: | | | | – | | The current IVD landscape and impact of the COVID-19 pandemic | | | | – | | Challenges facing manufacturers across the IVD lifecycle | | | | – | | Steps for implementing a successful transition strategy | | | | |
| |
| |
Want to reach 22,000+ medtech executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.
About this email: You are receiving this message as part of your complimentary newsletter subscription to MedTech Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. MedTech Dive is a product of Industry Dive, Inc. 1255 23rd Street NW, Suite 550 Washington DC 20037
0 Comments